MapLight Therapeutics, Inc.
MPLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $760 | $760 | $760 | $760 |
| - Cash | $64 | $33 | $50 | $38 |
| + Debt | $6 | $6 | $6 | $7 |
| Enterprise Value | $702 | $733 | $716 | $728 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$31 | -$30 | -$22 | -$23 |
| % Margin | – | – | – | – |
| Net Income | -$29 | -$30 | -$22 | -$21 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.71 | -0.72 | -0.54 | -0.51 |
| % Growth | 1.4% | -33.3% | -5.9% | – |
| Operating Cash Flow | -$32 | -$34 | -$26 | -$21 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$32 | -$34 | -$26 | -$22 |